Heart failure (HF) is one of the most common comorbidities among patients who undergo
transcatheter aortic valve implantation (TAVI).
1
Current literature on short-term outcomes among these high-risk patients remains
limited. Hence, we evaluated the 30-day readmission outcomes of patients hospitalized
with HF during index admission for TAVI.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Aortic stenosis and heart failure: disease ascertainment and statistical considerations for clinical trials.Card Fail Rev. 2019; 5: 99-105
Centers for Medicare and Medicaid Services. Hospital Readmissions Reduction Program (HRRP). Available at:https://www.cms.gov/medicare/medicare-fee-for-service-payment/acuteinpatientpps/readmissions-reduction-program.html. Accessed on 7/8/2022.
- Composite metric for benchmarking site performance in transcatheter aortic valve replacement: results From the STS/ACC TVT registry.Circulation. 2021; 144: 186-194
The Society of Thoracic Surgeons. Online STS adult cardiac surgery risk calculator, 2017. Available at: http://riskcalc.sts.org/stswebriskcalc/calculate. Accessed on 7/8/2022.
- Prosthesis-patient mismatch in patients undergoing transcatheter aortic valve replacement: from the STS/ACC TVT Registry.J Am Coll Cardiol. 2018; 72: 2701-2711https://doi.org/10.1016/j.amjcard.2022.06.005
Article Info
Publication History
Published online: July 16, 2022
Received:
May 25,
2022
Publication stage
In Press Journal Pre-ProofIdentification
Copyright
© 2022 Elsevier Inc. All rights reserved.
